Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
dc.article.end-page | 794 | en |
dc.article.start-page | 783 | en |
dc.citation.doi | 10.1056/NEJMOA2216455 | en |
dc.contributor.author | Tadashi Matsushita | en |
dc.contributor.author | A Shapiro | en |
dc.contributor.author | P Abraham | en |
dc.contributor.author | P Angchaisuksiri | en |
dc.contributor.author | Johnny Mahlangu | en |
dc.contributor.author | E et al | en |
dc.date.accessioned | 2024-07-23T05:55:18Z | |
dc.date.available | 2024-07-23T05:55:18Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.issn | 0028-4793 | en |
dc.identifier.uri | https://hdl.handle.net/10539/39122 | |
dc.journal.title | Phase 3 Trial of Concizumab in Hemophilia with Inhibitors | en |
dc.journal.volume | 389 | en |
dc.publisher | WILEY-BLACKWELL | en |
dc.title | Phase 3 Trial of Concizumab in Hemophilia with Inhibitors | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 1.23 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client